患有或没有慢性阻塞性肺病的呼吸器相关肺炎患者的临床结果
Caiden Taowei Lu1,2, Tien-Pei Fang2, Ming-Szu Hung2,3
1Institute of Emergency and Critical Care Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.
Journal of the Chinese Medical Association : JCMA
|October 1, 2024
概括
慢性阻塞性肺病 (COPD) 患有呼吸器相关性肺炎 (VAP) 的患者与没有COPD的患者相比,临床结果和细菌原因相似. 这项研究没有发现VAP的COPD患者的死亡率增加或住院时间延长.
科学领域:
- 关键护理医学 关键护理医学
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
背景情况:
- 慢性阻塞性肺病 (COPD) 是一个主要的全球健康问题,在恶化期间经常需要侵入性机械通风 (IMV).
- 呼吸机相关肺炎 (VAP) 是重症监护室 (ICU) 中常见的,往往致命的并发症.
- 关于COPD对VAP发展和结果的具体影响的研究有限.
研究的目的:
- 为了比较细菌病原体和VAP的临床结果在患者和没有先前存在的COPD.
- 调查这两个群体之间的重症监护室 (ICU) 和住院时间,IMV持续时间和死亡率的差异.
主要方法:
- 从2015年1月到2019年12月,对175名VAP患者进行了回顾性观察性研究.
- 经过支气管扩展后的肺功能测试证实了COPD的诊断.
- 细菌原因,ICU/住院时间,IMV持续时间和死亡率的比较.
主要成果:
- 44%的VAP患者先前患有COPD;在入院时,疾病的严重程度类似.
- Pseudomonas aeruginosa,Acinetobacter spp. 和 Klebsiella pneumoniae 是最常见的病原体. 这些是最常见的病原体.
- 两组之间在多抗药性隔离物,ICU/住院时间,IMV持续时间或死亡率方面没有发现显著差异.
结论:
- 在患有VAP的患者中,COPD与更糟糕的临床结果无关.
- 在COPD患者和没有COPD患者之间,VAP的细菌原因没有显著差异.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Pneumonia III: Complications and Assessment
182
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
182
Pneumonia I: Introduction
213
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
213
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K


